Literature DB >> 1903340

Antimicrobial activity of subinhibitory concentrations of aminoglycosides against Pseudomonas aeruginosa as determined by the killing-curve method and the postantibiotic effect.

G G Zhanel1, J A Karlowsky, D J Hoban, R J Davidson.   

Abstract

This investigation used the postantibiotic effect (PAE) and killing curves to provide data on the antimicrobial activity of subinhibitory (1/8x, 1/4x and 1/2x minimum inhibitory concentration; MIC) and inhibitory (1x MIC) concentrations of amikacin, gentamicin and tobramycin against Pseudomonas aeruginosa. Subinhibitory concentrations (1/4x and 1/2x MIC) of aminoglycosides demonstrated a reproducible PAE. At 1/4x MIC, the order of duration of the PAE was approximately 15 min for all aminoglycosides, while at 1/2x MIC all three aminoglycosides displayed a similar PAE of approximately 40 min. Killing-curve studies demonstrated that subinhibitory concentrations of aminoglycosides either decrease bacterial growth for several hours (1/4x and 1/2x MIC) or produce stasis of growth for several hours (1/8x MIC). Only inhibitory aminoglycoside concentrations (1x MIC) proved to be bactericidal. Subinhibitory concentrations of aminoglycosides decrease bacterial growth and produce a PAE against P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903340     DOI: 10.1159/000238842

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  13 in total

1.  Subinhibitory antimicrobial concentrations: A review of in vitro and in vivo data.

Authors:  G G Zhanel; D J Hoban; G K Harding
Journal:  Can J Infect Dis       Date:  1992-07

2.  Antipseudomonal agents exhibit differential pharmacodynamic interactions with human polymorphonuclear leukocytes against established biofilms of Pseudomonas aeruginosa.

Authors:  Athanasios Chatzimoschou; Maria Simitsopoulou; Charalampos Antachopoulos; Thomas J Walsh; Emmanuel Roilides
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Postantibiotic effects of gentamicin and netilmicin on Serratia marcescens: effects on hydrophobicity and motility.

Authors:  L Majtánová; V Majtán
Journal:  Folia Microbiol (Praha)       Date:  2000       Impact factor: 2.099

4.  Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in vitro dynamic model.

Authors:  F Maggiolo; A Taras; S Frontespezi; M C Legnani; M A Silanos; G Pravettoni; F Suter
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 5.  Pharmacological considerations for the proper clinical use of aminoglycosides.

Authors:  Spyridon Pagkalis; Elpis Mantadakis; Michael N Mavros; Christina Ammari; Matthew E Falagas
Journal:  Drugs       Date:  2011-12-03       Impact factor: 9.546

6.  Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.

Authors:  V Majtán; A Hostacká
Journal:  Folia Microbiol (Praha)       Date:  1996       Impact factor: 2.099

7.  In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.

Authors:  J A Karlowsky; M H Saunders; G A Harding; D J Hoban; G G Zhanel
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

8.  Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin.

Authors:  I Odenholt-Tornqvist; E Löwdin; O Cars
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

Review 9.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

10.  Effect of pooled human cerebrospinal fluid on the postantibiotic effects of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli.

Authors:  G G Zhanel; J A Karlowsky; R J Davidson; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.